Table 2 Case characteristics at the time of diagnosis
N(%) | |||
|---|---|---|---|
40–60 years (n = 777) | 40–50 years (n = 333) | 60 years (n = 444) | |
Follow-up time | |||
≥ 5, < 10 years | 368 (47) | 118 (35) | 250 (56) |
≥ 10 years | 409 (53) | 215 (65) | 194 (44) |
Age at diagnosis | |||
< 65 years | 282 (36) | 276 (83) | 6 (1) |
≥ 65 years | 495 (64) | 57 (17) | 438 (99) |
Tumour differentiationa | |||
Poorly | 114 (15) | 33 (10) | 81 (18) |
Highly/intermediately | 656 (84) | 299 (90) | 357 (81) |
Missing | 7 (1) | 1 (0) | 6 (1) |
Primary tumour | |||
Non-assessed (TX) | 15 (2) | 9 (3) | 6 (1) |
Non-palpable (T1) | 433 (56) | 209 (63) | 224 (50) |
Localised (T2) | 248 (32) | 94 (28) | 154 (35) |
Non-localised (T3–T4) | 74 (9) | 18 (5) | 56 (13) |
Missing | 7 (1) | 3 (1) | 4 (1) |
Serum PSA | |||
≤ 50 ng/mL | 703 (90) | 314 (94) | 389 (88) |
> 50 ng/mL | 67 (9) | 18 (6) | 49 (11) |
Missing | 7 (1) | 1 (0) | 6 (1) |
Disease aggressivenessb | |||
Non-aggressive | 608 (78) | 289 (87) | 319 (72) |
Aggressive | 169 (22) | 44 (13) | 125 (28) |